Somkiat Sunpaweravong

Suggest Changes

Writes About:

Learn More
4085 Background: ESCC remains a devastating cancer in Southern Thailand and novel therapeutic approach needs to be explored. EGFR tyrosine kinase (TK) inhibitor is a potential therapeutic agent(More)